Delcath Systems (NASDAQ: DCTH)

High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Delcath Systems (NASDAQ: DCTH) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About Delcath Systems (NASDAQ: DCTH)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients